Zomig (zolmitriptan) for migraines
October 1998
Pfizer is now marketing Zomig (zolmitriptan) for migraines.
It's the third "triptan" on the market...after sumatriptan (Imitrex) and naratriptan (Amerge).
Think of Zomig as similar to sumatriptan. They both have a fast onset and short duration of action.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote